{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:04:52Z","timestamp":1787238292328,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.prostaglandins.2014.09.002","type":"journal-article","created":{"date-parts":[[2014,9,26]],"date-time":"2014-09-26T18:03:33Z","timestamp":1411754613000},"page":"62-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["PGE2 reduces MMP-14 and increases plasminogen activator inhibitor-1 in cardiac fibroblasts"],"prefix":"10.1016","volume":"113-115","author":[{"given":"Kamal M.","family":"Kassem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarette H.","family":"Clevenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Szandzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2014.09.002_bib0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jcp.20064","article-title":"Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP)","volume":"200","author":"Osenkowski","year":"2004","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.prostaglandins.2014.09.002_bib0010","doi-asserted-by":"crossref","first-page":"L683","DOI":"10.1152\/ajplung.00187.2011","article-title":"Pulmonary fibroblasts mobilize the membrane-tethered matrix metalloprotease, MT1-MMP, to destructively remodel and invade interstitial type I collagen barriers","volume":"301","author":"Rowe","year":"2011","journal-title":"Am J Physiol Lung: Cell Mol Physiol"},{"key":"10.1016\/j.prostaglandins.2014.09.002_bib0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jtcvs.2010.09.051","article-title":"Extracellular matrix metalloproteinase inducer (CD147) and membrane type 1-matrix metalloproteinase are expressed on tissue macrophages in calcific aortic stenosis and induce transmigration in an artificial valve model","volume":"142","author":"Joghetaei","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.prostaglandins.2014.09.002_bib0020","doi-asserted-by":"crossref","first-page":"H623","DOI":"10.1152\/ajpheart.00746.2009","article-title":"Gene expression profiling of dilated cardiomyopathy in older male EP4 knockout mice","volume":"298","author":"Harding","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.prostaglandins.2014.09.002_bib0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1161\/01.HYP.25.3.421","article-title":"Effects of interleukin-1 beta and nitric oxide on cardiac myocytes","volume":"25","author":"Harding","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.prostaglandins.2014.09.002_bib0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/abio.1999.4085","article-title":"Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro","volume":"270","author":"Winer","year":"1999","journal-title":"Anal Biochem"},{"key":"10.1016\/j.prostaglandins.2014.09.002_bib0035","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.prostaglandins.2014.09.002_bib0040","doi-asserted-by":"crossref","first-page":"30316","DOI":"10.1074\/jbc.M110.158196","article-title":"Cardiac restricted overexpression of membrane type-1 matrix metalloproteinase causes adverse myocardial remodeling following myocardial infarction","volume":"285","author":"Spinale","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2014.09.002_bib0045","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1095\/biolreprod.111.093278","article-title":"Oxytocin increases invasive properties of endometrial cancer cells through phosphatidylinositol 3-kinase\/AKT-dependent up-regulation of cyclooxygenase-1, -2, and X-linked inhibitor of apoptosis protein","volume":"85","author":"Dery","year":"2011","journal-title":"Biol Reprod"},{"key":"10.1016\/j.prostaglandins.2014.09.002_bib0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1755-5922.2010.00207.x","article-title":"Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction","volume":"30","author":"Lindsey","year":"2012","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.prostaglandins.2014.09.002_bib0055","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1172\/JCI38369","article-title":"The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice","volume":"120","author":"Bauman","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.prostaglandins.2014.09.002_bib0060","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0002-9440(10)63135-5","article-title":"Increased expression of plasminogen activator inhibitor-1 in cardiomyocytes contributes to cardiac fibrosis after myocardial infarction","volume":"164","author":"Takeshita","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.prostaglandins.2014.09.002_bib0065","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1210\/en.2008-0591","article-title":"Prostaglandin E2 acts via multiple receptors to regulate plasminogen-dependent proteolysis in the primate periovulatory follicle","volume":"150","author":"Markosyan","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.prostaglandins.2014.09.002_bib0070","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0303-7207(94)90081-7","article-title":"Transcriptional regulation of plasminogen activator inhibitor-1 expression in human synovial fibroblasts by prostaglandin E2: mediation by protein kinase A and role of interleukin-1","volume":"103","author":"DiBattista","year":"1994","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.prostaglandins.2014.09.002_bib0075","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1093\/carcin\/bgn202","article-title":"Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms","volume":"29","author":"Neil","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.prostaglandins.2014.09.002_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2011.01.003","article-title":"Prostaglandin E2 increases cardiac fibroblast proliferation and increases cyclin D expression via EP1 receptor","author":"Harding","year":"2011","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.prostaglandins.2014.09.002_bib0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/jmcc.2001.1484","article-title":"Cyclooxygenase-2 in myocardium stimulation by angiotensin-II in cultured cardiac fibroblasts and role at acute myocardial infarction","volume":"34","author":"Scheuren","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.prostaglandins.2014.09.002_bib0090","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1165\/rcmb.2004-0126OC","article-title":"Prostaglandin E(2) inhibits fibroblast migration by E-prostanoid 2 receptor-mediated increase in PTEN activity","volume":"32","author":"White","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.prostaglandins.2014.09.002_bib0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-1-4615-5385-4_4","article-title":"Regulation and role of myocardial collagen matrix remodeling in hypertensive heart disease","volume":"432","author":"Funck","year":"1997","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.prostaglandins.2014.09.002_bib0100","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4049\/jimmunol.180.1.637","article-title":"Prostaglandin E2 mediates IL-1beta-related fibroblast mitogenic effects in acute lung injury through differential utilization of prostanoid receptors","volume":"180","author":"White","year":"2008","journal-title":"J Immunol"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882314000458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882314000458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T23:54:03Z","timestamp":1538178843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882314000458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":20,"alternative-id":["S1098882314000458"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2014.09.002","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PGE2 reduces MMP-14 and increases plasminogen activator inhibitor-1 in cardiac fibroblasts","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2014.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}